Cite

1. Stucky CC, Johnson KN, Gray RJ, Stucky CC, Johnson KN, Gray RJ, et al. Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol 2012; 19: 878-85.10.1245/s10434-011-1978-721861229Search in Google Scholar

2. Van Herendael BH, Heyman SR, Vanhoenacker FM, De Temmerman G, Bloem JL, Parizel PM, et al. The value of magnetic resonance imaging in the differentiation between malignant peripheral nerve-sheath tumors and non-neurogenic malignant soft-tissue tumors. Skeletal Radiol 2006; 35: 745-53.10.1007/s00256-006-0160-y16775712Search in Google Scholar

3. Ramanathan RC, Thomas JM. Malignant peripheral nerve sheath tumours associated with von Recklinghausen’s neurofibromatosis. Eur J Surg Oncol 1999; 25: 190-3.10.1053/ejso.1998.062510218464Search in Google Scholar

4. Shimizu J, Arano Y, Murata T, Ishikawa N, Yachi T, Nomura T, et al. A case of intrathoracic giant malignant peripheral nerve sheath tumor in neurofibromatosis type I (von Recklinghausen’s disease). Ann Thorac CardiovascSurg 2008; 14: 42-7.Search in Google Scholar

5. Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, et al. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer 2006; 107: 1065-74.10.1002/cncr.2209816881077Search in Google Scholar

6. McConnell YJ, Giacomantonio CA. Malignant triton tumors-complete surgical resection and adjuvant radiotherapy associated with improved survival. J Surg Oncol 2012; 106: 51-6.10.1002/jso.2304222253011Search in Google Scholar

7. Kamran SC, Howard SA, Shinagare AB, Krajewski KM, Jagannathan JP, Hornick JL, et al. Malignant peripheral nerve sheath tumors: Prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location. Eur J Surg Oncol 2013; 39: 46-52.10.1016/j.ejso.2012.09.00123084090Search in Google Scholar

8. Kim JG, Sung WJ, Kim DH, Kim YH, Sohn SK, Lee KB. Malignant peripheral nerve sheath tumor in neurofibromatosis type I: unusual presentation of intraabdominal or intrathoracic mass. Korean J Intern Med 2005; 20: 100-4.10.3904/kjim.2005.20.1.100389140515906964Search in Google Scholar

9. Chu YC, Yoon YH, Han HS, Han JY, Kim JM, Park IS. Malignant transformation of intrathoracic ancient neurilemmoma in a patient without von Recklinghausen’s disease. J Korean Med Sci 2003; 18: 295-8.10.3346/jkms.2003.18.2.295305503412692434Search in Google Scholar

10. McLaughlin EJ, Heuer GG, Whitmore RG, Birknes JK, Belasco J, Sterman D, et al. Treatment of a malignant peripheral nerve sheath tumor and its complications through a multidisciplinary approach. J Neurosurg Pediatr 2011; 7: 543-8.10.3171/2011.2.PEDS117521529197Search in Google Scholar

11. Patel VS, St Louis JD, Oduntan O, Landolfo KP. Intrathoracic peripheral nerve sheath tumors in patients with neurofibromatosis type 1 (von Recklinghausen disease). J Thorac Cardiovasc Surg 2006; 131: 736-7.10.1016/j.jtcvs.2005.11.02416515934Search in Google Scholar

12. Park JH, Choi KH, Lee HB, Rhee YK, Lee YC, Chung MJ. Intrathoracic malignant peripheral nerve sheath tumor in von Recklinghausen’s disease. Korean J Intern Med 2001; 16: 201-4.10.3904/kjim.2001.16.3.201453172911769579Search in Google Scholar

13. Chao BH, Stogner-Underwood KA, Kiev J, Smith TJ. Intrathoracic malignant peripheral nerve sheath tumor in neurofibromatosis 1. J Clin Oncol 2008; 26: 2216-8.10.1200/JCO.2007.14.675318445849Search in Google Scholar

14. Yamaguchi M, Yoshino I, Fukuyama S, Osoegawa A, Kameyama T, Tagawa T, et al. Surgical treatment of neurogenic tumors of the chest. Ann ThoracCardiovasc Surg 2004; 10: 148-51.Search in Google Scholar

15. Podobnik J, Kocijancic I, Kovac V, Sersa I. 3T MRI in evaluation of asbestosrelated thoracic diseases-preliminary results. Radiol Oncol 2012; 44: 92-6.Search in Google Scholar

16. Levy AD, Patel N, Dow N, Abbott RM, Miettinen M, Sobin LH. From the archives of the AFIP: abdominal neoplasms in patients with neurofibromatosis type 1: radiologic-pathologic correlation. Radiographics 2005; 25: 455-80.10.1148/rg.25204517615798063Search in Google Scholar

17. Murphey MD, Smith WS, Smith SE, Kransdorf MJ, Temple HT. From the archives of the AFIP. Imaging of musculoskeletal neurogenic tumors: radiologic- pathologic correlation. Radiographics 1999; 19: 1253-80.10.1148/radiographics.19.5.g99se10125310489179Search in Google Scholar

18. Li CS, Huang GS, Wu HD, Chen WT, Shih LS, Lii JM, et al. Differentiation of soft tissue benign and malignant peripheral nerve sheath tumors with magnetic resonance imaging. Clin Imaging 2008; 32: 121-7.10.1016/j.clinimag.2007.05.00618313576Search in Google Scholar

19. Bredella MA, Torriani M, Hornicek F, Ouellette HA, Plamer WE, Williams Z, et al. Value of PET in the assessment of patients with neurofibromatosis type 1. AJR Am J Roentgenol 2007; 189: 928-35.10.2214/AJR.07.206017885067Search in Google Scholar

20. Wasa J, Nishida Y, Tsukushi S, Shido Y, Sugiura H, Nakashima H, et al. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas. AJR Am J Roentgenol 2010; 194: 1568-74.10.2214/AJR.09.272420489098Search in Google Scholar

21. Bhargava R, Parham DM, Lasater OE, Chari RS, Chen G, Fletcher BD. MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol 1997; 27: 124-9.10.1007/s0024700500829028843Search in Google Scholar

22. Mautner VF, Asuagbor FA, Dombi E, Fünsterer C, Kluwe L, Wenzel R, et al. Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1. Neuro Oncol 2008; 10: 593-8.10.1215/15228517-2008-011266623318559970Search in Google Scholar

23. Van Meerbeeck SF, Verstraete KL, Janssens S, Mortier G. Whole body MR imaging in neurofibromatosis type 1. Eur J Radiol 2009; 69: 236-42.10.1016/j.ejrad.2008.10.02419091504Search in Google Scholar

eISSN:
1581-3207
ISSN:
1318-2099
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Radiology, Internal Medicine, Haematology, Oncology